143 related articles for article (PubMed ID: 33226093)
1. Shorter drug testing intervals are associated with improved drug misuse rates.
Gudin J; Mehta N; McClure FL; Niles JK; Kaufman HW
J Opioid Manag; 2020 Sep/Oct 2020; 16(5):357-373. PubMed ID: 33226093
[TBL] [Abstract][Full Text] [Related]
2. Treatment changes following aberrant urine drug test results for patients prescribed chronic opioid therapy.
Morasco BJ; Krebs EE; Cavanagh R; Hyde S; Crain A; Dobscha SK
J Opioid Manag; 2015; 11(1):45-51. PubMed ID: 25750164
[TBL] [Abstract][Full Text] [Related]
3. Do Urine Drug Tests Reveal Substance Misuse Among Patients Prescribed Opioids for Chronic Pain?
Larochelle MR; Cruz R; Kosakowski S; Gourlay DL; Alford DP; Xuan Z; Krebs EE; Yan S; Lasser KE; Samet JH; Liebschutz JM
J Gen Intern Med; 2022 Aug; 37(10):2365-2372. PubMed ID: 34405344
[TBL] [Abstract][Full Text] [Related]
4. Rate of Fentanyl Positivity Among Urine Drug Test Results Positive for Cocaine or Methamphetamine.
LaRue L; Twillman RK; Dawson E; Whitley P; Frasco MA; Huskey A; Guevara MG
JAMA Netw Open; 2019 Apr; 2(4):e192851. PubMed ID: 31026029
[TBL] [Abstract][Full Text] [Related]
5. Correlates of opiate misuse based on aberrant urine drug tests for patients on chronic opiate therapy in a safety-net, academic primary care clinic.
Bakhai S; Thilagar B; Reynolds JL; Leonard KE
J Opioid Manag; 2018; 14(1):23-33. PubMed ID: 29508893
[TBL] [Abstract][Full Text] [Related]
6. Review of the Current State of Urine Drug Testing in Chronic Pain: Still Effective as a Clinical Tool and Curbing Abuse, or an Arcane Test?
Chakravarthy K; Goel A; Jeha GM; Kaye AD; Christo PJ
Curr Pain Headache Rep; 2021 Feb; 25(2):12. PubMed ID: 33598816
[TBL] [Abstract][Full Text] [Related]
7. Clinician Response to Aberrant Urine Drug Test Results of Patients Prescribed Opioid Therapy for Chronic Pain.
Morasco BJ; Krebs EE; Adams MH; Hyde S; Zamudio J; Dobscha SK
Clin J Pain; 2019 Jan; 35(1):1-6. PubMed ID: 30222612
[TBL] [Abstract][Full Text] [Related]
8. Analysis of Urine Drug Test Results From Substance Use Disorder Treatment Practices and Overdose Mortality Rates, 2013-2020.
Whitley P; LaRue L; Fernandez SA; Passik SD; Dawson E; Jackson RD
JAMA Netw Open; 2022 Jun; 5(6):e2215425. PubMed ID: 35657623
[TBL] [Abstract][Full Text] [Related]
9. Urine Drug Testing among Opioid-Naïve and Long-Term Opioid Nevada Medicaid Beneficiaries.
Friedman S; Patel K; Liu Y; Hartzell S; Keller MS
Subst Use Misuse; 2020; 55(14):2314-2320. PubMed ID: 32835582
[TBL] [Abstract][Full Text] [Related]
10. Urine drug testing in the context of opioid analgesic prescribing for chronic pain: a content analysis of U.S. state laws in 2022.
Andraka-Christou B; McAvoy E; Gordon AJ; Ohama M; Brach M; Taylor EA; Vaiana M; Saloner B; Stein BD
Pain Med; 2023 Dec; 24(12):1306-1317. PubMed ID: 37551941
[TBL] [Abstract][Full Text] [Related]
11. Physician Renewal of Chronically Prescribed Controlled Substances Based on Urine Drug Test Results.
Hosain F; Lee J; Ata A; Bhullar RK; Chang AK
J Prim Care Community Health; 2019; 10():2150132719883632. PubMed ID: 31646927
[No Abstract] [Full Text] [Related]
12. Describing prescription opioid adherence among individuals with chronic pain using urine drug testing.
Matteliano D; Chang YP
Pain Manag Nurs; 2015 Feb; 16(1):51-9. PubMed ID: 24939349
[TBL] [Abstract][Full Text] [Related]
13. Urine drug testing in chronic pain.
Christo PJ; Manchikanti L; Ruan X; Bottros M; Hansen H; Solanki DR; Jordan AE; Colson J
Pain Physician; 2011; 14(2):123-43. PubMed ID: 21412368
[TBL] [Abstract][Full Text] [Related]
14. Prescription opioid abuse and misuse: gap between primary-care investigator assessment and actual extent of these behaviors among patients with chronic pain.
Setnik B; Roland CL; Pixton GC; Sommerville KW
Postgrad Med; 2017 Jan; 129(1):5-11. PubMed ID: 27782769
[TBL] [Abstract][Full Text] [Related]
15. Systematic urine drug testing for detecting and managing opioid misuse among chronic noncancer pain patients in primary care-The HARMS Program: A retrospective chart review of 77 patients.
Shahi N; Patchett-Marble R
J Opioid Manag; 2020; 16(4):277-282. PubMed ID: 32885835
[TBL] [Abstract][Full Text] [Related]
16. Predictors of urine drug testing for patients with chronic pain: Results from a national cohort of U.S. veterans.
Morasco BJ; Peters D; Krebs EE; Kovas AE; Hart K; Dobscha SK
Subst Abus; 2016; 37(1):82-7. PubMed ID: 26516794
[TBL] [Abstract][Full Text] [Related]
17. Urine Drug Testing Among Patients Prescribed Long-Term Opioid Therapy: Patient and Clinician Factors.
Agnoli AL; Howe R; Magnan E; Jerant A; Colby D; Franks P
J Am Board Fam Med; 2023 Aug; 36(4):537-541. PubMed ID: 37468213
[TBL] [Abstract][Full Text] [Related]
18. Comparative evaluation of the accuracy of immunoassay with liquid chromatography tandem mass spectrometry (LC/MS/MS) of urine drug testing (UDT) opioids and illicit drugs in chronic pain patients.
Manchikanti L; Malla Y; Wargo BW; Fellows B
Pain Physician; 2011; 14(2):175-87. PubMed ID: 21412372
[TBL] [Abstract][Full Text] [Related]
19. Responsible, Safe, and Effective Prescription of Opioids for Chronic Non-Cancer Pain: American Society of Interventional Pain Physicians (ASIPP) Guidelines.
Manchikanti L; Kaye AM; Knezevic NN; McAnally H; Slavin K; Trescot AM; Blank S; Pampati V; Abdi S; Grider JS; Kaye AD; Manchikanti KN; Cordner H; Gharibo CG; Harned ME; Albers SL; Atluri S; Aydin SM; Bakshi S; Barkin RL; Benyamin RM; Boswell MV; Buenaventura RM; Calodney AK; Cedeno DL; Datta S; Deer TR; Fellows B; Galan V; Grami V; Hansen H; Helm Ii S; Justiz R; Koyyalagunta D; Malla Y; Navani A; Nouri KH; Pasupuleti R; Sehgal N; Silverman SM; Simopoulos TT; Singh V; Solanki DR; Staats PS; Vallejo R; Wargo BW; Watanabe A; Hirsch JA
Pain Physician; 2017 Feb; 20(2S):S3-S92. PubMed ID: 28226332
[TBL] [Abstract][Full Text] [Related]
20. Assessment, stratification, and monitoring of the risk for prescription opioid misuse and abuse in the primary care setting.
Brown J; Setnik B; Lee K; Wase L; Roland CL; Cleveland JM; Siegel S; Katz N
J Opioid Manag; 2011; 7(6):467-83. PubMed ID: 22320029
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
